ArticleBMC public health2026
A HIV status-stratified analysis of Mpox risk factors among MSM in Mainland China over two years (2023-2024).
Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe global Mpox epidemic has disproportionately affected men who have sex with men (MSM). This study describes the factors associated with Mpox infection among Chinese MSM and examines whether these factors differ between HIV-positive MSM and HIV-negative MSM.
methodsWe conducted online cross-sectional surveys in August-September 2023 and 2024, recruiting 15,848 MSM from 30 provinces in China. Weighted logistic regression models were then used to estimate the self-reported Mpox infection, stratified by HIV status.
resultsAmong 170 reported Mpox cases, 47.1% were HIV-positive. In the overall sample, higher education and income were associated with lower risk, while international travel was associated with higher risk. When stratified by HIV status, the associated factors differed. For HIV-positive MSM, having sexual partners with skin rash symptoms and STD infection were significantly associated with Mpox infection. For HIV-negative MSM, group sex and lower attention to Mpox information were significantly associated with infection.
conclusionHIV status defines divergent Mpox risk profiles among Chinese MSM. An effective response requires differentiated strategies: integration of Mpox prevention into HIV care cascade systems for people living with HIV, and the implementation of behavior-focused interventions for HIV-negative MSM. Longitudinal studies grounded in behavioral and network theories are now urgently needed to establish causal pathways, elucidate the mechanisms driving these divergent risk architectures, and evaluate the long-term effectiveness of stratified intervention approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.